| Patents for C07K 5 - Peptides having up to four amino acids in a fully defined sequence; Derivatives thereof (30,692) |
|---|
| 08/08/1995 | US5439812 Antibodies catalyzing deamidation of proteins |
| 08/08/1995 | US5439806 Carboxylate protective groups, a process for their preparation, their coupling to a functional group, and their use |
| 08/03/1995 | WO1995020603A1 Inhibitors of serine proteases, bearing a chelating group |
| 08/03/1995 | WO1995020598A1 Method of separating and purifying trh analogs and process for producing solvates of trh analogs |
| 08/03/1995 | WO1995020591A1 Phenylboronic acid complexes |
| 08/03/1995 | WO1995020581A1 Novel human leukocyte elastase (hle) inhibitors, and related pharmaceutical compositions and methods of use |
| 08/03/1995 | WO1995020396A1 Inhibitors of geranylgeranyl-protein transferase |
| 08/03/1995 | CA2182203A1 Novel human leukocyte elastase (hle) inhibitors, and related pharmaceutical compositions and methods of use |
| 08/03/1995 | CA2181252A1 Phenylboronic acid complexes |
| 08/03/1995 | CA2180528A1 Inhibitors of geranylgeranyl-protein transferase |
| 08/03/1995 | CA2179889A1 Inhibitors of serine proteases, bearing a chelating group |
| 08/02/1995 | EP0665215A1 1,4-Diamino-2,3-dihydroxybutanes |
| 08/02/1995 | EP0664789A1 Inhibitors of farnesyl protein transferase |
| 08/02/1995 | EP0489860B1 Methods and compositions for healing ulcers |
| 08/01/1995 | US5438119 Preferential binding of peptide having desired activity or receptivity, then separation from mixed peptides |
| 08/01/1995 | US5438118 Peptide mimics having constrained peptide backbone |
| 08/01/1995 | US5437982 Methods of identifying specific inactivation gate inhibitors of the sodium channel |
| 08/01/1995 | CA1336528C Antimalarial amnioquinoline derivatives, process for their preparation and pharmaceutical composition containing them |
| 07/27/1995 | WO1995019965A1 Synthetic matrix metalloprotease inhibitors and uses thereof |
| 07/27/1995 | WO1995019958A1 Malarial aspartic protease inhibitors |
| 07/27/1995 | DE4337271A1 ubstd. heterocyclic carboxylic acid amides and their prepn. |
| 07/27/1995 | CA2181551A1 Malarial aspartic protease inhibitors |
| 07/27/1995 | CA2158760A1 Synthetic matrix metalloprotease inhibitors and uses thereof |
| 07/26/1995 | EP0664338A1 Enzymatic coupling of L-phenylalanine methyl ester and N-benzyloxycarbonyl-aspartic acid |
| 07/26/1995 | EP0663856A1 Apparatus and method for multiple simultaneous synthesis |
| 07/26/1995 | EP0663823A1 Inhibition of angiogenesis by synthetic matrix metalloprotease inhibitors |
| 07/25/1995 | US5436229 Bisulfite adducts of arginine aldehydes |
| 07/25/1995 | US5436221 Oligopeptides as antitumor agents |
| 07/20/1995 | WO1995019567A1 Synthetic receptors, libraries and uses thereof |
| 07/20/1995 | CA2180844A1 Synthetic receptors, libraries and uses thereof |
| 07/19/1995 | CN1105355A Modlar design and synthesis of aminimide-containing molecules |
| 07/19/1995 | CN1105285A Process and apparatus for recovery of raw materials in the aspartame reparation process |
| 07/18/1995 | US5434261 Benzo-fused lactams promote release of growth hormone |
| 07/18/1995 | US5434248 Peptidyl derivatives as inhibitors of interleukin-1β converting enzyme |
| 07/18/1995 | CA1336349C Nitrogenous polycyclic tripeptides, their preparation and pharmaceutical compositions containing them |
| 07/18/1995 | CA1336348C Process for industrial synthesis of perindopril and its major synthesis intermediates |
| 07/13/1995 | WO1995018972A1 Systematic modular production of aminimide- and oxazolone-based molecules having selected properties |
| 07/13/1995 | CA2180527A1 Method of making polymers having specific properties |
| 07/13/1995 | CA2180526A1 Method of identifying chemical compounds having selected properties for a particular application |
| 07/12/1995 | EP0662481A1 Spiro piperidines and homologs promote release of growth hormone |
| 07/12/1995 | EP0662145A1 Process for the selective increase of production of antibiotic ge 2270 factor a. |
| 07/12/1995 | EP0662134A1 Polypeptides involved in streptogramin biosynthesis, nucleotide sequences coding for said polypeptides and use thereof |
| 07/12/1995 | EP0662081A1 Ureido-acetamide derivatives, preparation thereof and drugs containing same. |
| 07/12/1995 | EP0662079A1 Alpha-helix mimetics and methods relating thereto |
| 07/12/1995 | EP0661986A1 Brain-enhanced delivery of neuroactive peptides by sequential metabolism |
| 07/11/1995 | US5432262 Method of purifying α-L-aspartyl-L-phenylalanine methyl ester |
| 07/11/1995 | US5432186 Enzyme inhibitors |
| 07/11/1995 | US5432159 N-(α-substituted-pyridinyl)carbonyl dipeptide antihypertensive agents |
| 07/11/1995 | US5432018 Peptide library and screening systems |
| 07/11/1995 | US5431842 Liquid detergents with ortho-substituted phenylboronic acids for inhibition of proteolytic enzyme |
| 07/06/1995 | WO1995018186A1 Modular design and synthesis of aminimide containing molecules |
| 07/06/1995 | WO1995017903A1 Modular design and synthesis of oxazolone-derived molecules |
| 07/06/1995 | DE4344958A1 New substd. pyridine cpds. |
| 07/06/1995 | CA2179984A1 Modular design and synthesis of oxazolone-derived molecules |
| 07/06/1995 | CA2179983A1 Modular design and synthesis of aminimide containing molecules |
| 07/05/1995 | EP0661383A2 Method for the determination of thrombocyte aggregation |
| 07/05/1995 | EP0661292A1 Orally active renin inhibitors |
| 07/05/1995 | EP0661269A1 Substituted heterocyclic carboxylic acid amides, their preparation and their use as medicaments |
| 07/05/1995 | EP0328634B1 Pharmaceutical compositions for the treatment of psoriasis |
| 07/05/1995 | CN1104646A Peptides |
| 07/05/1995 | CN1104634A Compounds with a sulphamoyl and amidino group, process for preparing them and pharmaceutical compositions containing them |
| 07/04/1995 | US5430182 Substituted acyl derivative; high sweetening potency and stability; for soft drinks |
| 07/04/1995 | US5430155 1,4-diamine-2,3-dihydroxy butanes |
| 07/04/1995 | US5430151 Trifluoromethyl-containing pseudopeptides active against retroviruses |
| 07/04/1995 | US5430150 N-(1-(((1H-benzimidazol-2-ylmethyl)amino)carbonyl)-2-methyl -butyl)-3-(((1,1-dimethylethyl)amino)-carbonyl)decahydro-gamma-hydroxyalpha -(phenylmethyl)-2-isoquinolinepentanamide compounds; AIDS |
| 07/04/1995 | US5430145 Mercaptoacetylamide derivatives useful as inhibitors of enkephalinase and ace |
| 07/04/1995 | US5430128 Peptidyl derivatives as inhibitors of interleukin-1β converting enzyme |
| 07/04/1995 | US5430045 Administering an L-2-oxothiazolidine-4-carboxylate to patient receiving AZT |
| 07/04/1995 | US5430044 Arylalkyl-amines and -amides having anticonvulsant and neuroprotective properties |
| 07/04/1995 | US5430025 Elastase-inhibiting peptides bearing a C-terminal trifluoromethylketone moiety |
| 07/04/1995 | US5430024 Peptides bearing N-terminal amidino moieties and their use as inhibitors of platelet aggregation |
| 07/04/1995 | US5430023 Tripeptide antithrombotic agents |
| 07/04/1995 | US5430022 Endothelin antagonists; hypotensive agents; treatment for angina pectoris, brain disorders, asthma, renal failure |
| 07/01/1995 | CA2138929A1 Substituted heterocyclic carboxamides, their preparation and their use as pharmaceuticals |
| 06/29/1995 | WO1995017423A1 Compounds with growth hormone releasing properties |
| 06/29/1995 | WO1995017422A1 Compounds with growth hormone releasing properties |
| 06/29/1995 | WO1995017419A1 Metal chelators |
| 06/29/1995 | WO1995017418A2 NOVEL INTERMEDIATES FOR THE SYNTHESIS OF L-ASPARTYL-D-α-AMINOALKANOYL-(S)-N-α-ALKYLBENZYL AMIDES USEFUL AS ARTIFICIAL SWEETENERS |
| 06/29/1995 | WO1995017204A1 Composition and methods to improve neural outcome |
| 06/29/1995 | CA2179598A1 Compounds with growth hormone releasing properties |
| 06/29/1995 | CA2179597A1 Compounds with growth hormone releasing properties |
| 06/29/1995 | CA2179379A1 Metal chelators |
| 06/29/1995 | CA2179376A1 Novel intermediates for the synthesis of l-aspartyl-d-.alpha.-aminoalkanoyl-(s)-n-.alpha.-alkylbenzyl amides useful as artificial sweeteners |
| 06/29/1995 | CA2178711A1 Composition and methods to improve neural outcome |
| 06/28/1995 | EP0659764A2 Peptides modified by the phosphine group for marking with 99mTC and 186-188Re or paramagnetic agents |
| 06/28/1995 | EP0659755A1 Phospholipids as vectors for active molecules, their preparation and their use in cosmetic or dermatologic compositions |
| 06/28/1995 | EP0659214A1 Allergenic proteins and peptides from japanese cedar pollen |
| 06/28/1995 | EP0659193A1 Platelet aggregation inhibitors |
| 06/28/1995 | EP0659188A1 Methods for the synthesis of phosphonate esters |
| 06/28/1995 | EP0659184A1 Optically active hydroquinine (amino-3 phenyl)-1 ethanesulfonate, preparation and use thereof. |
| 06/28/1995 | EP0659181A1 Sulfonamide inhibitors of hiv-aspartyl protease |
| 06/28/1995 | EP0659179A1 Benzo-fused lactams promote release of growth hormone |
| 06/28/1995 | EP0659175A1 Optically active alkylammonium (amino-3 phenyl)-1 ethanesulfonate derivatives, preparation and use thereof. |
| 06/28/1995 | CN1104217A Peptides having T cell helper activity |
| 06/28/1995 | CA2139014A1 Phospholipids comprising an active molecule, their preparation and their use in cosmetic or dermatologic compositions |
| 06/27/1995 | US5428158 2-substituted indane-2-mercaptoacetylamide derivatives useful as inhibitors of enkephalinase and ace |
| 06/27/1995 | US5428128 Forming amino acid chain of polypeptide, conjugating non-antigenic polymer to blocking groups, introducing said polymer at each point of synthesis, continuing synthesis of amino acid chain |
| 06/27/1995 | US5428021 Human leukocyte elastase (HLE) inhibitors, and related pharmaceutical compositions and methods of use |
| 06/27/1995 | US5428019 Bombesin analogs |
| 06/27/1995 | US5427958 Detecting presence of autoantibodies in biological fluids; forming peptide complexes; in vitro; diagnosing lupus, autoimmune diseases |